Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-05-26 07:08 am Sale | 13D | CALITHERA BIOSCIENCES INC CALA | TAKEDA PHARMACEUTICAL CO LTD TAK | 0 0.000% | -857,844 (Position Closed) | View |
| 2023-02-14 11:48 am Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 488,367 9.990% | 488,367 (New Position) | View |
| 2023-02-14 08:02 am Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | CITADEL ADVISORS LLC | 249,336 5.100% | 249,336 (New Position) | View |
| 2023-02-09 4:02 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | PRIMECAP MANAGEMENT CO | 401,080 8.240% | 201,117 (+100.58%) | View |
| 2023-02-09 4:01 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | PRIMECAP MANAGEMENT CO | 199,963 4.110% | -206,317 (-50.78%) | View |
| 2023-02-08 4:05 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | INCYTE CORP INCY | 0 0.000% | -1,720,430 (Position Closed) | View |
| 2022-12-08 11:49 am Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | PRIMECAP MANAGEMENT CO | 406,280 8.350% | 406,280 (New Position) | View |
| 2022-07-06 06:12 am Sale | 13D | CALITHERA BIOSCIENCES INC CALA | TAKEDA PHARMACEUTICAL CO LTD TAK | 857,844 15.000% | -13,959,640 (-94.21%) | View |
| 2022-04-21 06:06 am Purchase | 13D | CALITHERA BIOSCIENCES INC CALA | TAKEDA PHARMACEUTICAL CO LTD TAK | 14,817,484 13.200% | 14,817,484 (New Position) | View |
| 2022-04-11 4:03 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | CITADEL ADVISORS LLC | 5,035,077 5.400% | 1,404,529 (+38.69%) | View |
| 2022-02-14 06:26 am Sale | 13G | CALITHERA BIOSCIENCES INC CALA | CITADEL ADVISORS LLC | 3,630,548 4.800% | -53,595 (-1.45%) | View |
| 2022-02-10 12:22 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | PRIMECAP MANAGEMENT CO | 10,733,000 14.320% | 479,500 (+4.68%) | View |
| 2022-02-10 09:12 am Sale | 13G | CALITHERA BIOSCIENCES INC CALA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -4,000,000 (Position Closed) | View |
| 2022-02-09 3:33 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | VANGUARD GROUP INC | 2,861,596 3.820% | -813,098 (-22.13%) | View |
| 2021-12-10 1:13 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | FEDERATED HERMES INC. FHI | 1,418 0.000% | -7,441,182 (-99.98%) | View |
| 2021-11-22 4:05 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | CITADEL ADVISORS LLC | 3,684,143 4.900% | 3,684,143 (New Position) | View |
| 2021-07-12 08:29 am Sale | 13G | CALITHERA BIOSCIENCES INC CALA | BlackRock Inc. BLK | 2,796,097 3.800% | -2,872,303 (-50.67%) | View |
| 2021-07-08 5:00 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 7,452,331 10.100% | 3,091,093 (+70.88%) | View |
| 2021-02-16 3:32 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | Point72 Asset Management L.P. | 1,734,364 2.500% | -1,505,682 (-46.47%) | View |
| 2021-02-12 1:18 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | FEDERATED HERMES INC. FHI | 7,442,600 10.550% | 508,000 (+7.33%) | View |